KalVista Pharmaceuticals Aktie
13,10
EUR
-0,10
EUR
-0,76
%
15,57
USD
-0,24
USD
-1,52
%
Werbung
KalVista Pharmaceuticals Aktie Analyse
20.03.19 | KalVista Pharmaceuticals Buy | Needham & Company, LLC | |
21.09.18 | KalVista Pharmaceuticals Overweight | Cantor Fitzgerald | |
31.08.17 | KalVista Pharmaceuticals Buy | BTIG Research |
Werbung
Werbung